Ambrx Biopharma Other Current Assets

Ambrx Biopharma (AMAM) currently reports a other current assets of $810K as of September 2023. That compares with $5.7M in the prior-year period — down 85.9% year over year. Use the charts on this page to explore Ambrx Biopharma's other current assets history and peer comparisons.

Ambrx Biopharma's other current assets decreased from $5.7M to $810K — a 85.9% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ambrx Biopharma reported $810K in other current assets as of September 2023. That compares with $5.7M in the prior-year period — down 85.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $810K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ambrx Biopharma, and consider following AMAM for alerts when major investors trade the stock.

Ambrx Biopharma is classified in the Healthcare sector. On other current assets, it currently shows $810K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMAM with unrelated industries.